Fennec Pharmaceuticals In... (FENC)
NASDAQ: FENC
· Real-Time Price · USD
8.39
-0.14 (-1.64%)
At close: Aug 15, 2025, 3:59 PM
8.36
-0.36%
After-hours: Aug 15, 2025, 04:10 PM EDT
Fennec Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.38M | -436K | -1.21M | 2.63M | 2.74M | -16.1M | -20.2M | -26.44M | -26.07M | -23.71M | -21.28M | -17.38M | -16.31M | -17.35M | -16.16M | -18.17M | -19.02M |
Depreciation & Amortization | 167K | 864K | 1.08M | 991K | 892K | 221K | 111K | 171.4K | 258.4K | 212.4K | 88.4K | 36K | 22K | 16K | 410K | 757K | 787K |
Stock-Based Compensation | 4.67M | 5.06M | 4.79M | 3.84M | 5.46M | 5.35M | 5.35M | 6.38M | 4.84M | 4.15M | 4.2M | 3.23M | 3.55M | 3.75M | 3.42M | 3.76M | 2.98M |
Other Working Capital | -16.62M | 7.08M | 7.86M | 23.93M | 25.19M | 1.41M | 1.98M | 1.68M | 1.67M | 1.61M | 490K | 43K | -65K | -138K | 55K | -598K | -518K |
Other Non-Cash Items | 25.05M | 25.48M | 26.21M | 4.97M | 666.01K | 287.01K | 223.24K | 274K | 238K | 320K | 730K | 613K | 660K | 346K | -6K | 341K | 287K |
Deferred Income Tax | n/a | n/a | -73K | -73K | n/a | n/a | 73K | 12.6K | -60.4K | -66.4K | -74.4K | -61K | -61K | -55K | -449K | -757K | -787K |
Change in Working Capital | -23.76M | n/a | -3.17M | 14.76M | 17.65M | -6.83M | -4.59M | -1.66M | 78K | 1.1M | 1.87M | 1.11M | -1.35M | -932K | -1.48M | -2.68M | 315K |
Operating Cash Flow | -16.04M | 27.33M | 23.83M | 23.3M | 27.4M | -17.23M | -19.06M | -21.34M | -20.78M | -18.06M | -14.5M | -12.45M | -13.48M | -14.22M | -14.26M | -16.75M | -15.44M |
Capital Expenditures | n/a | n/a | n/a | -3.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 3.37 | 3.37 | 3.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | 5.09M | 5.09M | 5.09M | 5.09M | -65K | 19.93M | 19.93M | 19.93M | 20M | n/a | 5M | 5M | 5M | 5M | n/a |
Common Stock Repurchased | 19K | n/a | -17K | -50K | -77K | -78K | -89K | -241K | -214K | -194K | -166K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -12.48M | -13.97M | -1.78M | -1.27M | -649.29K | 675.71K | 1.58M | 1.44M | 975K | 797K | -82K | 71K | -7K | -22K | 430K | 313K | 322K |
Financial Cash Flow | -12.13M | -13.63M | 4.42M | 5.15M | 5.42M | 6.74M | 1.73M | 21.38M | 20.91M | 20.73M | 19.92M | 100.72K | 5.02M | 5.01M | 5.46M | 5.31M | 32.29M |
Net Cash Flow | -28.46M | 13.41M | 27.96M | 28.1M | 32.75M | -10.55M | -17.39M | 43K | 131K | 2.67M | 5.42M | -12.38M | -8.49M | -9.24M | -8.83M | -11.44M | 16.85M |
Free Cash Flow | -16.04M | 27.15M | 23.65M | 23.13M | 27.22M | -17.23M | -19.06M | -21.34M | -20.78M | -18.06M | -14.5M | -12.45M | -13.48M | -14.22M | -14.26M | -16.75M | -15.44M |